Notice: This company has been marked as potentially delisted and may not be actively trading. LumiraDx (LMDX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period LumiraDx Ltd LMDXFApril 14, 2024 | morningstar.comLMDX.OJanuary 31, 2024 | reuters.comWhy LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving PremarketJanuary 8, 2024 | msn.comWhy Is LumiraDx (LMDX) Stock Down 13% Today?January 8, 2024 | investorplace.comLumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9thJanuary 5, 2024 | finance.yahoo.comRoche (RHHBY) to Acquire LumiraDx's Point of Care TechnologyJanuary 2, 2024 | msn.comRoche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295MJanuary 2, 2024 | benzinga.comWhy LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving PremarketJanuary 2, 2024 | benzinga.comLumiraDx falls on agreement with Roche to sell assetsJanuary 2, 2024 | msn.comRoche to buy part of LumiraDx diagnostics platform for $295 millionDecember 29, 2023 | reuters.comLumiraDx Inc: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to RocheDecember 29, 2023 | finanznachrichten.deRoche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platformDecember 29, 2023 | finance.yahoo.comLumiraDx Agrees To Sell Point-of-Care Tech Platform To RocheDecember 29, 2023 | markets.businessinsider.comLumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to RocheDecember 29, 2023 | finance.yahoo.comLumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to RocheDecember 29, 2023 | finance.yahoo.comTrading was temporarily halted for "LMDX" at 04:12 PM with a stated reason of "News pending."December 29, 2023 | marketbeat.comLumiraDx Limited (LMDX)December 26, 2023 | uk.finance.yahoo.comLumiraDx (LMDX) Price Target Increased by 12.50% to 1.22November 27, 2023 | msn.comLumiraDx Ltd LMDXNovember 15, 2023 | morningstar.comWhy Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving PremarketNovember 2, 2023 | benzinga.comWhy Pinterest Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving PremarketOctober 31, 2023 | benzinga.comLumiraDx Inc: LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to AppealOctober 28, 2023 | finanznachrichten.deLumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to AppealOctober 27, 2023 | finance.yahoo.comWhy Is LumiraDx (LMDX) Stock Down 35% Today?October 24, 2023 | msn.comLumiraDx Inc: LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England's First Heart & Lung Screening HubOctober 20, 2023 | finanznachrichten.deLumiraDx Limited (LMDX) Loses -25.54% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerSeptember 27, 2023 | finance.yahoo.comWhat Makes LumiraDx Limited (LMDX) a New Buy StockSeptember 21, 2023 | finance.yahoo.comBTIG Keeps Their Buy Rating on LumiraDx (LMDX)August 27, 2023 | markets.businessinsider.comEarnings Update: LumiraDx Limited (NASDAQ:LMDX) Just Reported And Analysts Are Trimming Their ForecastsAugust 27, 2023 | finance.yahoo.comLumiraDx Limited (NASDAQ:LMDX) Q2 2023 Earnings Call TranscriptAugust 25, 2023 | finance.yahoo.comLumiraDx Reports Second Quarter 2023 ResultsAugust 24, 2023 | finance.yahoo.comLumiraDx Limited (LMDX) Reports Q2 Loss, Misses Revenue EstimatesAugust 24, 2023 | finance.yahoo.comThis LumiraDx Insider Increased Their Holding By 150% Last YearAugust 21, 2023 | finance.yahoo.comLumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24August 16, 2023 | finance.yahoo.comCapitalGainsReport Potential Breakouts Watchlist (SHGI, IQST, PHUN LMDX)August 1, 2023 | benzinga.comPositive Sentiment Still Eludes LumiraDx Limited (NASDAQ:LMDX) Following 27% Share Price SlumpAugust 1, 2023 | finance.yahoo.comLumiraDx Submits Medical Device Application To FDA For COVID Ultra TestJune 30, 2023 | markets.businessinsider.comLumiraDx Submits First 510(k) Application to the FDA for COVID Ultra TestJune 30, 2023 | finance.yahoo.comLumiraDx shares are trading higher after the company received UK approval for its COVID Ultra and COVID & RSV Tests.June 21, 2023 | benzinga.comLumiraDX Skyrockets on Bagging Approval for COVID-19 and RSV Tests in the U.K.June 21, 2023 | msn.comWhy Is LumiraDx (LMDX) Stock Up 30% Today?June 21, 2023 | investorplace.comLumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV TestsJune 20, 2023 | finance.yahoo.comLMDX - LumiraDx LimitedJune 6, 2023 | ca.finance.yahoo.comLadenburg Thalmann Maintains LumiraDx (LMDX) Buy RecommendationMay 18, 2023 | msn.comGoldman Sachs Maintains LumiraDx (LMDX) Neutral RecommendationMay 18, 2023 | msn.comThe Latest Analyst Ratings for LumiraDxMay 17, 2023 | markets.businessinsider.comRaymond James Maintains LumiraDx (LMDX) Outperform RecommendationMay 17, 2023 | msn.comAnalysts Offer Insights on Healthcare Companies: LumiraDx (LMDX) and Aerovate Therapeutics (AVTE)May 16, 2023 | markets.businessinsider.comLumiraDx: Q1 Earnings InsightsMay 16, 2023 | msn.comLumiraDx Limited (LMDX) Reports Q1 Loss, Tops Revenue EstimatesMay 16, 2023 | finance.yahoo.com Get LumiraDx News Delivered to You Automatically Sign up to receive the latest news and ratings for LMDX and its competitors with MarketBeat's FREE daily newsletter. Email Address 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << LMDX Media Mentions By Week LMDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LMDX News Sentiment▼0.000.60▲Average Medical News Sentiment LMDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LMDX Articles This Week▼01▲LMDX Articles Average Week Get LumiraDx News Delivered to You Automatically Sign up to receive the latest news and ratings for LMDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bolt Biotherapeutics News Today Tenax Therapeutics News Today NeuroBo Pharmaceuticals News Today Citius Pharmaceuticals News Today Cadrenal Therapeutics News Today MIRA Pharmaceuticals News Today Unity Biotechnology News Today Carisma Therapeutics News Today Pieris Pharmaceuticals News Today Aprea Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LMDX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LumiraDx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share LumiraDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LMDX Stock Alerts